-
Bharat Biotech’s US partner Ocugen submits ‘Master File’ to FDA on Covaxin
Ocugen is expecting the vaccine to be rolled out in the US during the second half of the year 2021.
-
Covaxin effective against India, UK coronavirus strains: Bharat Biotech
Citing a study published in peer-reviewed medical journal Clinical Infectious Diseases, Bharat Biotech noted that vaccination with Covaxin produced ne
-
Covid Vaccination: Bharat Biotech’s Covaxin approved for phase 2/3 trials on children
In the trial, the vaccine will be given by intramuscular route in two doses on day 0 and day 28.
-
Will raise monthly production of vaccines to 10 crore doses by August: Serum Institute
Bharat Biotech also submitted to the Centre their production plan for the next four months. It said it can ramp up production to 7.8 crore doses by Au
-
Bharat Biotech says can’t provide additional Covaxin doses to Delhi: Manish Sisodia
Covaxin stock in Delhi has finished and as a result around 100 vaccination centres set up in 17 schools have been closed, Sisodia said
-
Bharat Biotech’s Covaxin recommended by expert panel for phase 2/3 trials on 2-18 year-olds
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur
-
Direct supply of Covaxin to 18 states since May 1: Bharat Biotech
The states include Andhra Pradesh, Delhi, Bihar, Gujarat, Haryana, Uttar Pradesh and West Bengal, Bharat Biotech said
-
Tech transfers, supply of materials must to scale up vaccine production: Bharat Biotech joint MD Suchitra Ella
She noted that collaborations are necessary to cater to vaccination needs of a huge country like India
-
Full advance of Rs 1,700 crore released to SII for 11 crore Covishield doses on April 28: Govt
The amount, which after TDS was Rs 1699.50 crore, was received by the SII on April 28
-
Bharat Biotech vaccine price: Covaxin now at Rs 400 for state governments
As per the statement issued by Bharat Biotech, they have reduced the price to Rs. 400 for state governments after recognizing the enormous challenges
